logo
Select company
Select metric
$ -10.66MEarnings Before Interest Taxes & Depreciation Amortization (EBITDA)
VS
Market
25
Sector
60
Industry
76
History
78
$ 3.3Close
$ 0.9 - $ 3.3 52-Week Range
Ticker Information

Ticker

ARMP

Company Name

ARMATA PHARMACEUTICALS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NYSEMKT

ARMATA PHARMACEUTICALS INC - Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

ARMP - EBITDA Historical data
DateDepreciation, Amortization & AccretionEarning Before Interest & Taxes (EBIT)Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)
6/30/2025$ 1.44M$ -12.09M$ -10.66M
3/31/2025$ 1.39M$ 12.1M$ 13.48M
12/31/2024$ 1.32M$ -8.17M$ -6.85M
9/30/2024$ 1.24M$ -32.45M$ -31.21M
6/30/2024$ 1.15M$ -59.88M$ -58.73M
3/31/2024$ 1.06M$ -75.13M$ -74.07M
12/31/2023$ 972K$ -66.42M$ -65.45M
9/30/2023$ 924K$ -58.34M$ -57.41M
6/30/2023$ 929K$ -36.97M$ -36.04M
3/31/2023$ 896K$ -42.63M$ -41.74M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • ARMATA PHARMACEUTICALS INC's latest trailing twelve months (TTM) EBITDA stands at $ -18.34M.
  • Over the past 5 years, ARMATA PHARMACEUTICALS INC's average EBITDA has been $ -30.84M.
  • The median EBITDA for ARMATA PHARMACEUTICALS INC during this period was $ -26.88M
  • ARMATA PHARMACEUTICALS INC reached its highest EBITDA over the past 5 years at $ 13.48M.
  • The lowest EBITDA recorded by ARMATA PHARMACEUTICALS INC in the same timeframe $ -74.07M

ARMATA PHARMACEUTICALS INC's EBITDA vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

EBITDA Benchmarks
CompanyEBITDA
CBUS : CIBUS INC $ -234.61MACOG : ALPHA COGNITION INC $ -19.86MPYXS : PYXIS ONCOLOGY INC $ -95.04MORMP : ORAMED PHARMACEUTICALS INC $ -34.88MNTRB : NUTRIBAND INC $ -9.95MPSTV : PLUS THERAPEUTICS INC $ -14.57MDYAI : DYADIC INTERNATIONAL INC $ -5.09MALGS : ALIGOS THERAPEUTICS INC $ -58.76MTCRX : TSCAN THERAPEUTICS INC $ -130.55MIMDX : INSIGHT MOLECULAR DIAGNOSTICS INC $ -61.35M

Similar metrics to EBITDA:

Definition of Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

[Calculation] EBITDA is a non-GAAP accounting metric that lets investors asses profitability net of expenses dependent on financing decision, tax strategy and depreciation schedules. It is calculated by adding depreciation and amortisation expenses [DepAmor] back to [EBIT].
EBIT + DepAmor
(=) EBITDA EBITDA for ARMATA PHARMACEUTICALS INC is calculated as follows: EBIT [ $ -19.49M ] + DepAmor [ $ 1.14M ]
(=) EBITDA [ $ -18.34M ]

ARMP - Earnings Before Interest Taxes & Depreciation Amortization (EBITDA), Last 5 years

$ -74.07M

Minimum

Mar 31, 2024

$ 13.48M

Maximum

Mar 31, 2025

$ -30.84M

Average

$ -26.88M

Median

EBITDA Benchmark Analysis

 The chart above depicts the distribution of EBITDA for companies in the Total Stock Market. The average EBITDA of the companies is $ 58.76M with a standard deviation of $ 167.31M.
The following table provides additional summary stats:
EBITDA in the Market:
filtered constituents3.24K
min$ -494.95M
max$ 590.6M
average$ 58.76M
median$ 8.92M
std$ 167.31M